A1M Pharma

Activities: Research & Development

Trending Articles

  1. OINDPs: Nosey about recent developments? OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
  2. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Compact process thermostat for efficient temperature control in the laboratory The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
  5. AviadoBio expands presence at Canary Wharf The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Recruitment

A1M Pharma appoints Chief Medical Officer
Research & Development

A1M Pharma selects Research Toxicology Centre for preclinical toxicology studies on novel pre-eclampsia drug

Agreement with RTC enables A1M Pharma to obtain the toxicity and safety data required to initiate clinical studies in humans
Research & Development

NeuroVive Pharmaceutical and A1M Pharma to collaborate on mitochondrial medicine

Initial purpose is to utilise the companies’ complementary scientific platforms within the framework of ongoing research projects
Subscribe now